PPA
IBB icon

Parametric Portfolio Associates’s iShares Biotechnology ETF IBB Stock Holding History

Parametric Portfolio Associates’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$1.16M Sell
8,924
-1,214
-12% -$158K ﹤0.01% 2712
2021
Q4 		$1.55M Buy
10,138
+568
+6% +$87.9K ﹤0.01% 2598
2021
Q3 		$1.55M Buy
9,570
+549
+6% +$92.4K ﹤0.01% 2578
2021
Q2 		$1.48M Buy
9,021
+2,820
+45% +$434K ﹤0.01% 2596
2021
Q1 		$934K Buy
6,201
+1,088
+21% +$173K ﹤0.01% 3191
2020
Q4 		$775K Sell
5,113
-586
-10% -$83.7K ﹤0.01% 3176
2020
Q3 		$772K Buy
5,699
+328
+6% +$44.5K ﹤0.01% 3065
2020
Q2 		$734K Buy
5,371
+2,094
+64% +$267K ﹤0.01% 3086
2020
Q1 		$353K Sell
3,277
-41
-1% -$4.72K ﹤0.01% 3346
2019
Q4 		$400K Sell
3,318
-467
-12% -$52.1K ﹤0.01% 3450
2019
Q3 		$377K Sell
3,785
-226
-6% -$23.7K ﹤0.01% 3442
2019
Q2 		$438K Sell
4,011
-1,926
-32% -$205K ﹤0.01% 3411
2019
Q1 		$664K Buy
5,937
+328
+6% +$36K ﹤0.01% 3211
2018
Q4 		$541K Buy
5,609
+246
+5% +$26.1K ﹤0.01% 3276
2018
Q3 		$654K Buy
5,363
+280
+6% +$33K ﹤0.01% 3310
2018
Q2 		$558K Buy
5,083
+52
+1% +$5.56K ﹤0.01% 3300
2018
Q1 		$537K Buy
5,031
+1,638
+48% +$182K ﹤0.01% 3313
2017
Q4 		$362K Sell
3,393
-15
-0.4% -$1.6K ﹤0.01% 3487
2017
Q3 		$379K Buy
3,408
+444
+15% +$47.5K ﹤0.01% 3568
2017
Q2 		$306K Buy
2,964
+237
+9% +$23.3K ﹤0.01% 3623
2017
Q1 		$267K Buy
+2,727
New +$261K ﹤0.01% 3487
2016
Q3 		– Sell
-2,334
Closed -$200K – 3785
2016
Q2 		$200K Buy
+2,334
New +$209K ﹤0.01% 3609

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Parametric Portfolio Associates's IBB Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its iShares Biotechnology ETF (IBB) stake by 12% in Q1 2022, selling an estimated $158K and leaving 8,924 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2712.

Parametric Portfolio Associates first reported a position in IBB in Q2 2016 and has held it in 22 quarters since. The position peaked at $1.55M in Q4 2021. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

  • Parametric Portfolio Associates held 8,924 shares of iShares Biotechnology ETF worth $1.16M as of Q1 2022.
  • Parametric Portfolio Associates sold 1,214 iShares Biotechnology ETF shares in Q1 2022, an estimated $158K.
  • iShares Biotechnology ETF made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2712 holding.
  • Parametric Portfolio Associates first reported a position in iShares Biotechnology ETF in Q2 2016 and has held it in 22 quarters since.
  • Parametric Portfolio Associates's iShares Biotechnology ETF position peaked at $1.55M in Q4 2021.
  • 897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.